| Autor: |
Madani N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. navid_madani@dfci.harvard.edu.; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA. navid_madani@dfci.harvard.edu.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, 02115, USA. navid_madani@dfci.harvard.edu., Princiotto AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Mach L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Ding S; Centre de Recherche du CHUM, Montreal, QC, H2X 0A9, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, H2X 0A9, Canada., Prevost J; Centre de Recherche du CHUM, Montreal, QC, H2X 0A9, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, H2X 0A9, Canada., Richard J; Centre de Recherche du CHUM, Montreal, QC, H2X 0A9, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, H2X 0A9, Canada., Hora B; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Sutherland L; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Zhao CA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Conn BP; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Bradley T; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Moody MA; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Melillo B; Department of Chemistry, University of Pennsylvania, Philadelphia, PA, 19104, USA., Finzi A; Centre de Recherche du CHUM, Montreal, QC, H2X 0A9, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, H2X 0A9, Canada., Haynes BF; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Smith Iii AB; Department of Chemistry, University of Pennsylvania, Philadelphia, PA, 19104, USA. smithab@sas.upenn.edu., Santra S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Sodroski J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. joseph_sodroski@dfci.harvard.edu.; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA. joseph_sodroski@dfci.harvard.edu.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. joseph_sodroski@dfci.harvard.edu. |
